Viagra (Sildenafil) and Anesthesia: Perioperative Interaction Guide

Sildenafil is not the same clinical situation in every patient who takes it. A person using Viagra as needed for erectile dysfunction is a different perioperative problem than a patient on scheduled Revatio for pulmonary arterial hypertension, because stopping the drug abruptly carries its own risk in the second group. Both are the same molecule and both interact with nitrates in the same way.

The core, quotable fact: the FDA label for sildenafil states that it is contraindicated with organic nitrates in any form, because the combination can cause a severe, additive drop in blood pressure through overlapping nitric oxide-cyclic GMP signaling (per the FDA-approved prescribing information for sildenafil). Anesthesia teams manage this by asking patients to disclose sildenafil use before any surgery, avoiding nitroglycerin and isosorbide drugs when sildenafil has been used recently, and keeping vasoconstrictor agents (phenylephrine, norepinephrine) ready instead. This is an FDA-labeled drug interaction, not a rare case report, but the precise number of hours during which risk is elevated after a given dose has not been established with the same precision as the interaction itself.

Why the interaction happens

Sildenafil blocks the enzyme that breaks down cyclic GMP in vascular smooth muscle, which lets nitric oxide signaling persist longer and produces sustained vasodilation. This is the same mechanism whether the drug is being used for erectile dysfunction or for pulmonary arterial hypertension. Nitrate drugs work through a related but distinct step: they donate nitric oxide directly. When both pathways are active at once, vasodilation becomes additive rather than simply overlapping, which is why the FDA treats the nitrate combination as an absolute contraindication rather than a caution.

Anesthesia and surgery introduce several other things that independently lower blood pressure: volatile anesthetic agents, propofol induction, and spinal or epidural blocks. None of these is itself contraindicated with sildenafil the way nitrates are. The concern is additive and dose-dependent: a patient who starts anesthesia with sildenafil still active has less blood-pressure reserve before any anesthetic drug is given, and that reserve keeps shrinking as induction proceeds. This is pharmacologically plausible and consistent with how each drug class behaves on its own, but it has not been quantified in controlled perioperative trials of sildenafil specifically. Statements that name an exact number of millimeters of mercury or a specific incidence of intraoperative hypotension attributable to sildenafil should be treated cautiously until verified against a primary source, and none is repeated here as a precise figure.

Why nitroglycerin becomes off-limits in the operating room

Nitroglycerin is a standard tool for treating intraoperative hypertension and coronary vasospasm, including during cardiac surgery. If a patient has taken sildenafil recently, that tool is unavailable, because giving nitroglycerin on top of active sildenafil risks a blood pressure drop that vasopressors may not easily reverse. This is the practical reason the FDA nitrate contraindication matters so much in a surgical setting: it is not just about avoiding a bad interaction on paper, it removes a first-line intraoperative drug from the anesthesiologist's options.

When nitrates cannot be used, anesthesiologists commonly turn to other agents for blood pressure control, such as calcium channel blockers (for hypertension) and phenylephrine or norepinephrine (for hypotension). The specific choice and protocol vary by institution and by the clinical situation, and represent site- and case-level judgment rather than a single FDA-mandated substitution list.

What to tell your surgical team, and when

Sildenafil for erectile dysfunction is often taken without a standing daily prescription in the medical record, and patients may not think to mention an as-needed drug the way they would a daily blood pressure pill. That reporting gap is a genuine, recognized problem in preoperative medication reconciliation generally, though the exact rate at which patients omit as-needed drugs specifically has not been verified here against a primary source and should not be quoted as a precise percentage without checking the original study.

Three things worth telling your anesthesia team, regardless of how the question is asked at your preoperative visit:

1. That you take sildenafil or any PDE5 inhibitor (tadalafil, vardenafil, avanafil), even occasionally.
2. The date and dose of your last use.
3. Whether you use any nitrate-containing medication, including sublingual nitroglycerin spray for chest pain, since sildenafil is contraindicated while that prescription is active.

For elective surgery, the common practice is to stop sildenafil at least 24 hours beforehand. This is standard anesthesia guidance rather than a number printed on the FDA label itself, and clinicians may extend it further in older patients or those with reduced liver function, since sildenafil clears more slowly in those groups. For emergency surgery where stopping in advance was not possible, disclosure still matters: it changes what the anesthesia team keeps out of reach (nitrates) and what they keep ready (vasopressors).

Pulmonary arterial hypertension is a different calculus

Some patients take sildenafil on a scheduled basis (marketed as Revatio) as an FDA-approved treatment for pulmonary arterial hypertension, rather than as-needed for erectile dysfunction. For this group, abruptly stopping sildenafil before surgery carries its own risk of rebound pulmonary hypertension and right heart strain, separate from the nitrate interaction discussed above. A randomized trial of sildenafil in pulmonary arterial hypertension (commonly referenced as SUPER-1) reported functional improvement with sildenafil versus placebo, but the exact trial numbers should be confirmed against the original publication before being cited precisely; they are not restated here as specific figures.

The decision to continue, bridge, or hold sildenafil in a patient with pulmonary arterial hypertension who needs surgery is not something a patient should decide alone. It requires coordination between the anesthesiologist and the physician managing the pulmonary hypertension, because the erectile-dysfunction dosing pattern and risk profile do not apply to this group.

Alcohol, and other drugs that compound the risk

The FDA label notes that combining sildenafil with alcohol can increase orthostatic hypotension and dizziness. In the days before surgery, that matters less for the interaction itself and more because alcohol independently affects the accuracy of NPO (nothing by mouth) instructions and aspiration risk; standard preoperative alcohol avoidance guidance applies regardless of sildenafil use.

Sildenafil is metabolized mainly through cytochrome P450 3A4. Drugs that inhibit that enzyme (some antifungals and macrolide antibiotics, for example) can raise sildenafil levels and prolong its effect; drugs that induce it can lower levels. The FDA label also describes an interaction with alpha-blockers (used for blood pressure or benign prostatic hyperplasia), where the combination can cause symptomatic hypotension. Patients on other blood-pressure-lowering medications should expect that sildenafil adds to, rather than replaces, those effects. None of this is unique to the perioperative setting, but it becomes more consequential when combined with anesthesia's own blood-pressure effects.

Resuming sildenafil after surgery

Sildenafil is generally considered reasonable to resume once a patient is hemodynamically stable, off vasopressors, and no longer being treated with nitrate-based therapy. For most outpatient elective procedures that may be as early as the next day, but this is a clinical judgment made by the treating physician, not a fixed rule. Patients who required prolonged vasopressor support, had cardiac surgery, or are discharged with a nitroglycerin prescription for chest pain should get explicit clearance before restarting sildenafil, since the nitrate contraindication remains in force for as long as that prescription is active.

What is established, what is plausible, and what still needs verification

Questions patients actually ask